Psychopathology and cognition in divergent functional outcomes in schizophrenia

Schizophrenia Research

Volumn 109, Issue 1-3, 2009, Pages 46-51

  Heinrichs, R Walter ^a   Ammari, Narmeen ^a   Miles, Ashley ^a   McDermid Vaz, Stephanie ^b   Chopov, Boyko ^a  

^a YORK UNIVERSITY   (Canada)

^b Cleghorn Early Intervention in Psychosis Program   (Canada)

Author keywords

Cognition; Functional outcome; Symptoms

Indexed keywords

ADULT; AGED; ARTICLE; COGNITION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PROGNOSIS; SCHIZOPHRENIA; VALIDATION STUDY;

ADAPTATION, PSYCHOLOGICAL; ADULT; COGNITION DISORDERS; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; SOCIAL ADJUSTMENT; SOCIAL SUPPORT;

EID: 62749160761     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2009.01.001     Document Type: Article

References (40)

1. American Psychiatric Association Task Force on DSM -IV. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (2000), APA, Washington, D.C
2. Benton A.L., Hamsher K.D., Rey G.J., and Sivan A.B. Multilingual Aphasia Examination (1994), AJA Associates, Iowa City, Iowa
3. Bowie C.R., Reichenberg A., Patterson T.L., Heaton R.K., and Harvey P.D. Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms. Am. J. Psychiatry 163 3 (2006) 418-425
4. Conners C.K. Conners' CPT-II for Windows (2000), Multi-Health Systems, North Tonawanda, New York
5. Delis D.C., Kramer J.H., Kaplan E., and Ober B.A. California Verbal Learning Test-2nd ed (CVLT-II) (2000), Psychological Corporation, San Antonio, Texas
6. Dollfus S., and Everitt B. Symptom structure in schizophrenia: two-three-or four-factor models?. Psychopath 31 3 (1998) 120-130
7. Dunayevich E., Ascher-Svanum H., Zhao F., Jacobson J.G., Phillips G.A., Dellva M.A., and Green A.I. Longer time to antipsychotic treatment discontinuation for any cause is associated with better functional outcomes for patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder. J. Clin. Psychiatry 68 8 (2007) 1163-1171
8. Emsley R., Chiliza B., and Schoeman R. Predictors of long-term outcome in schizophrenia. Curr. Opin. Psychiatry 21 2 (2008) 173-177
9. Evans J.D., Bond G.R., Meyer P.S., Kim H.W., Lysaker P.H., Gibson P.J., and Tunis S. Cognitive and clinical predictors of success in vocational rehabilitation in schizophrenia. Schizophr. Res. 70 2-3 (2004) 331-342
10. First, M.B., Spitzer, R.L., Gibbon, M., Williams, J.B.W., 1996. Structured Clinical Interview for DSM-IV Axis I Disorders, Non-Patient Edition (SCID-I/NP). New York State Psychiatric Institute, Biometrics Research, New York.
11. Goldberg T.E., Goldman R.S., Burdick K.E., Malhotra A.K., Lencz T., Patel R.C., Woerner M.G., Schooler N.R., Kane J.M., and Robinson D.G. Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?. Arch. Gen. Psychiatry 64 10 (2007) 1115-1122
12. Green M.F. Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. J. Clin. Psychiatry 67 suppl 9 (2006) 3-8
13. Green M.F. Stimulating the development of drug treatments to improve cognition in schizophrenia. Annu. Rev. Clin. Psychol. 3 (2007) 159-180
14. Green M.F., Kern R.S., Braff D.L., and Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?. Schizophr. Bull. 26 1 (2000) 119-136
15. Green M.F., Kern R.S., and Heaton R.K. Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr. Bull. 72 1 (2004) 41-51
16. Heinrichs R.W., and Zakzanis K.K. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 12 3 (1998) 426-445
17. Heinrichs R.W., Ammari N., McDermid Vaz S., and Miles A. Are schizophrenia and schizoaffective disorder neuropsychologically distinguishable?. Schizophr. Res. 99 1-3 (2008) 149-154
18. Heinrichs R.W., Miles A.A., Smith D., Zargarian T., Goldberg J.O., Ammari N., and McDermid Vaz S. Cognitive, clinical and functional characteristics of verbally superior schizophrenia patients. Neuropsychology 22 3 (2008) 321-328
19. Heinrichs, R.W., Ammari, N., Miles, A., McDermid Vaz, S., in press. Cognitive performance and functional competence as predictors of community independence in schizophrenia. Schizophr Bull. (advance access published July 30, 2008).
20. Helldin L., Kane J.M., Karilampi U., Norlander T., and Archer T. Remission in prognosis of functional outcome: a new dimension in the treatment of patients with psychotic disorders. Schizophr. Res. 93 1-3 (2007) 160-168
21. Jaeger J., Berns S.M., and Czobor P. The multidimensional scale of independent functioning: a new instrument for measuring functional disability in psychiatric populations. Schizophr. Bull. 29 1 (2003) 153-168
22. Kurtz M.M., Moberg P.J., Ragland J.D., Gur R.C., and Gur R.E. Symptoms versus neurocognitive test performance as predictors of psychosocial status in schizophrenia: a 1- and 4-year prospective study. Schizophr. Bull. 31 1 (2005) 167-174
23. Lindstrom E., Eberhard J., and Levander S. Five-year follow-up during antipsychotic treatment: efficacy, safety, functional and social outcome. Acta Psychiatr. Scand. Suppl. 435 (2007) 5-16
24. Lucas S., Fitzgerald D., Redoblado-Hodge M.A., Anderson J., Sanbrook M., Harris A., and Brennan J. Neuropsychological correlates of symptom profiles in first episode schizophrenia. Schizophr. Res. 71 2-3 (2004) 323-330
25. Marder S.R. Initiatives to promote the discovery of drugs to improve cognitive function in severe mental illness. J. Clin. Psychiatry 67 7 (2006) e03
26. Matza L.S., Buchanan R., Purdon S., Brewster-Jordan J., Zhao Y., and Revicki D.A. Measuring changes in functional status among patients with schizophrenia: the link with cognitive impairment. Schizophr. Bull. 32 4 (2006) 666-678
27. Mattsson M., Topor A., Cullberg J., and Forsell Y. Association between financial strain, social network and five-year recovery from first episode psychosis. Soc Psychiatry Psychiatr Epidemiol. 43 12 (2008) 947-952 (Dec)
28. McGurk S.R., and Mueser K.T. Cognitive functioning, symptoms, and work in supported employment: a review and heuristic model. Schizophr. Res. 70 2-3 (2004) 147-173
29. Milev P., Ho B.C., Arndt S., and Andreasen N.C. Predictive values of neurocognition and negative symptoms in functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. Am. J. Psychiatry 162 3 (2005) 495-506
30. Mishara A.L., and Goldberg T.E. A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book. Biol. Psychiatry 55 10 (2004) 1013-1022
31. Mohamed S., Rosenheck R., Swartz M., Stroup S., Lieberman J.A., and Keefe R.S. Relationship of cognition and psychopathology to functional impairment in schizophrenia. Am. J. Psychiatry 165 8 (2008) 978-987
32. Nuechterlein K.H., Barch D.M., Gold J.M., Goldberg T.E., Green M.F., and Heaton R.K. Identification of separable cognitive factors in schizophrenia. Schizophr. Res. 72 1 (2004) 29-39
33. Opler L.A., Kay S.R., Lindenmayer J.P., and Fiszbein A. Structured Clinical Interview for the Positive and Negative Syndrome Scale (SCI-PANSS) (1999), Multi-Health Systems, North Tonawanda, New York
34. Perlick D.A., Rosenheck R.A., Kaczynski R., Bingham S., and Collins J. Association of symptomatology and cognitive deficits to functional capacity in schizophrenia. Schizophr. Res. 99 1-3 (2008) 192-199
35. Remillard S., Pourcher E., and Cohen H. Long-term effects of risperidone versus haloperidol on verbal memory, attention, and symptomatology in schizophrenia. J. Int. Neuropsychol. Soc. 14 1 (2008) 110-118
36. Rocca P., Castagna F., Marchiaro L., Rasetti R., Rivoira E., and Bogetto F. Neuropsychological correlates of reality distortion in schizophrenic patients. Psychiatry Res 145 1 (2006) 49-60
37. San L., Ciudad A., Alvarez E., Bobes J., and Gilaberte I. Symptomatic remission and social/vocational functioning in outpatients with schizophrenia: prevalence and associations in a cross-sectional study. Eur. Psychiatry 22 8 (2007) 490-498
38. Twamley E.W., Doshi R.R., Nayak G.V., Palmer B.W., Golshan S., Heaton R.K., Patterson T.L., and Jeste D.V. Generalized cognitive impairments, ability to perform everyday tasks, and level of independence in community living situations of older patients with psychosis. Am. J. Psychiatry 159 12 (2002) 2013-2020
39. Wechsler D. Wechsler Adult Intelligence Scale, third edition (WAIS-III) (1997), Psychological Corporation, Harcourt Brace Jovanovich, San Antonio, Texas
40. Wittorf A., Wiedemann G., Buchkremer G., and Klingberg S. Prediction of community outcome in schizophrenia 1 year after discharge from impatient treatment. Eur. Arch. Psychiatry Clin. Neurosci. 258 1 (2008) 48-58